Using our previously developed high-throughput glycoproteomic workflow for a site-specific N-glycosylation LC-MS analysis of human C3 (10), here we aimed to explore whether C3 N-glycan changes accompany T1D complications’ severity and progression. Here, C3 is linked to type 1 diabetes mellitus.